COVID-19: Managing Anxiety and Depression
The outbreak of COVID-19 is challenging all of us to cope in new ways. For people with depression and anxiety, life can seem overwhelming in normal times. Rachel Yehuda, PhD, Professor of Psychiatry and Neuroscience at the Icahn School of Medicine at Mount Sinai...
How Epidemics Affect Our Mental Health
Craig Katz, MD, Clinical Professor of Psychiatry and Global Health, is the founder and director of Mount Sinai’s Global Mental Health Program. He organized the psychiatric response to 9/11 in New York City through an organization he co-founded, Disaster Psychiatry...
How to Talk to Your Child About COVID-19
Discussing difficult topics with children can be uncomfortable and this pandemic is no exception. Aliza Pressman, PhD, co-Founding Director and Director of Clinical Programming for the Mount Sinai Parenting Center, shares information parents and guardians can use as...
COVID-19: Coping and Resiliency Skills
As the outbreak of COVID-19 spreads throughout the greater New York area, people are adjusting to radical changes in their daily life. Businesses are closed, people are working from home—if they are able to work at all—and kids are trying to learn at home. It’s a...
Five Things to Know About Esketamine
In March 2019, intranasal esketamine—a form of ketamine marketed as SPRAVATO™ CIII Nasal Spray*—was approved by the U.S. Food and Drug Administration (FDA) to treat patients with treatment-resistant depression (TRD). James Murrough, MD, PhD, Director of Mount Sinai’s...
Partnering With the Community to Bring Mental Health Services to Those in Need
On Saturdays during the month of February, a group of organizations that support the homeless known as the Rescue Alliance, including Salvation Army, The Bowery Mission, Hope For New York, and New York City Relief, host an annual service event called Don’t Walk By....





